Nearly 1,000 food industry professionals will gather in Kalamazoo, Mich., March 24–25, 2026 for the WMU Food Marketing Conference. The event blends executive insight, emerging talent and timely topics—from AI to health and wellness—shaping food and CPG marketing.
- January 16, 2026
- 0 Comment
EcoVadis, a leading global provider of business sustainability ratings, has awarded the EXBERRY color supplier a Platinum medal. The achievement marks another important step forward for the company following Silver and Gold medals in the previous two assessment periods.
- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04141-4
In an arm of an ongoing multicenter phase 2 trial testing different therapies in patients with genetically profiled grade 2 or 3 meningiomas, treatment with an oral CDK4/6 inhibitor met the primary endpoint for progression-free survival at 6 months in patients with CDK or NF2 alterations.- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04163-y
Lessons from Rwanda’s response to the Marburg virus outbreak- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04160-1
Preparing for tomorrow’s threats by enhancing our ability to help patients today.- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-026-04211-1
Single-cell atlas of the developing Down syndrome brain cortex- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 15 January 2026; doi:10.1038/s41591-025-04071-1
In a prespecified secondary analysis of the SURMOUNT-OSA trial, tirzepatide improved cardiometabolic outcomes in patients with moderate-to-severe obstructive sleep apnea and obesity.- January 15, 2026
- 0 Comment
Nature Medicine, Published online: 15 January 2026; doi:10.1038/s41591-025-04132-5
In a long-term follow-up of the FAME 2 trial, fractional flow reserve-guided percutaneous coronary intervention plus medical therapy in patients with stable coronary artery disease reduced cardiovascular events compared to medical therapy alone, primarily due to a decrease in urgent revascularization events.- January 15, 2026
- 0 Comment
Nature Medicine, Published online: 15 January 2026; doi:10.1038/s41591-025-04188-3
Systematic examination of oxazolidinone analogs for activity against Mycobacterium tuberculosis and limited inhibition of the synthesis of mitochondrial proteins enabled the identification of several compounds with safety suitable for once-daily dosing. The lead molecule is effective in mouse models of disease and safe in four-month toxicity studies.- January 15, 2026
- 0 Comment
Nature Medicine, Published online: 15 January 2026; doi:10.1038/s41591-025-04147-y
An integrated analysis of 23,634 individuals identified 235 circulating metabolites associated with future risk of type 2 diabetes and revealed their potential genetic and environmental determinants. These findings provide a foundation for understanding the metabolic landscape underlying type 2 diabetes risk, informing preventative therapies that target specific metabolic pathways.- January 15, 2026
- 0 Comment
